Dr. Neal Rosen is a physician-scientist whose work in molecular pharmacology has played a pivotal role in advancing targeted cancer therapies and translational oncology. He joined Memorial Sloan Kettering Cancer Center (MSK) in the early 1980s and has been a key leader in bridging laboratory discovery with clinical application.
Dr. Rosen’s research has focused on signal transduction pathways in cancer, particularly mechanisms of oncogenic activation, drug resistance, and therapeutic response. His work has been instrumental in shaping the development of targeted treatments and combination strategies now widely used in clinical oncology.
Throughout his career at MSK, Dr. Rosen has held multiple leadership roles and has been deeply involved in mentoring trainees, junior investigators, and clinician-scientists. His contributions have helped define modern approaches to precision cancer medicine and have influenced both academic research and pharmaceutical development.
As an Emeritus Member, Dr. Rosen is recognized for his enduring impact on cancer research, his commitment to translational science, and his longstanding service to the MSK community.